Aft, Forsyth & Sober, LLC Amgen Inc Transaction History

Aft, Forsyth & Sober, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 14, 2020	SELL	$234.65 - $260.95 $41,063 - $45,666	-175 Closed	0 $0
Q2 2020 Aug 05, 2020	BUY	$197.81 - $242.74 $34,616 - $42,479	175 New	175 $41,000
Q1 2020 Apr 30, 2020	SELL	$182.24 - $241.7 $71,073 - $94,263	-390 Closed	0 $0
Q4 2019 Feb 06, 2020	BUY	$189.21 - $243.2 $73,791 - $94,848	390 New	390 $94,000

3,084

417M

7.18M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Aft, Forsyth & Sober, LLC, based on Form 13F filings with the SEC.

Stay updated on Aft, Forsyth & Sober, LLC with notifications on news.